I. Carvajal

发表

Anti-tumor effect of CT-322 as an Adnectin inhibitor of vascular endothelial growth factor receptor-2

Martin C. Wright, R. Kerbel, R. Mamluk, 2010, mAbs.

Functional Analysis of the Murine TCRβ-Chain Gene Enhancer1

R. Sen, I. Carvajal, 2000, The Journal of Immunology.

High-mobility group-I/Y proteins: potential role in the pathophysiology of critical illnesses.

R. Baron, I. Carvajal, M. Perrella, 2002, Critical care medicine.

Adnectin–drug conjugates for Glypican-3-specific delivery of a cytotoxic payload to tumors

Martin C. Wright, J. Bryson, V. Lafont, 2018, Protein engineering, design & selection : PEDS.

Nitric oxide synthase‐2 down‐regulates surfactant protein‐B expression and enhances endotoxin‐induced lung injury in mice

E. Ingenito, K. Haley, G. T. De Sanctis, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Modulation of the thioredoxin system during inflammatory responses and its effect on heme oxygenase-1 expression.

M. Layne, S. yet, I. Carvajal, 2002, Antioxidants and Redox Signaling.

Cyclooxygenase‐2 deficient mice are resistant to endotoxin‐induced inflammation and death

B. Levy, M. Layne, S. yet, 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations

A. Yamniuk, M. Graziano, T. Davidson, 2018, Regulatory toxicology and pharmacology : RTP.

Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels.

L. Fredenburgh, R. Baron, I. Carvajal, 2005, Cellular and molecular biology.

Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1–Deficient Mice

H. Rennke, K. Maemura, M. Layne, 2001, Circulation research.

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy

Justin K Scheer, R. Weissleder, A. Chakravarti, 2012, Journal of Neuro-Oncology.

Reduction of Nitric Oxide Synthase 2 Expression by Distamycin A Improves Survival from Endotoxemia1

M. Layne, Yen-Hsu Chen, R. Okabe, 2004, The Journal of Immunology.

Survival from Endotoxemia Expression by Distamycin A Improves Reduction of Nitric Oxide Synthase 2

M. Layne, Xiaoli Liu, L. Fredenburgh, 2004 .

-Chain Gene Enhancer Functional Analysis of the Murine TCR

R. Sen, I. Carvajal, 2000 .

Role of macrophage‐expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice

B. Schreiber, Dezheng Zhao, M. Layne, 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Functional analysis of the murine TCR beta-chain gene enhancer.

R. Sen, I. Carvajal, 2000, Journal of immunology.

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

Martin C. Wright, A. Yamniuk, M. Doyle, 2011, mAbs.

Adnectin CT-322 inhibits tumor growth and affects microvascular architecture and function in Colo205 tumor xenografts.

J. Peterson, E. Furfine, Steven R. O’Neil, 2010, International journal of oncology.

Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing’s sarcoma A673-xenograft growth and normalize tumor vascular architecture

Moritz A. Konerding, Maximilian Ackermann, M. Konerding, 2012, Angiogenesis.

Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity

Noah T. Ditto, M. Struthers, K. McIntyre, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Anti-VEGFR2 and anti-IGF-1R-Adnectins inhibit Ewing’s sarcoma A673-xenograft growth and normalize tumor vascular architecture

M. Konerding, M. Ackermann, I. Carvajal, 2012, Angiogenesis.